Status: Recruiting
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
The primary objective is to assess the safety and tolerability of oral dose ERX1000 in obese subjects.
Participants needed: 80
Trial details
Phase: Phase 2Age: 18-60Biological sex: AllType: InterventionalSponsor: ERX PharmaceuticalsUpdated: Jun 22, 2026Locations: 3
Eligibility criteria
Able to comprehend and willing to sign an ICF and to abide by the study requirem... [+11]
Poorly controlled severe psychiatric disorders (e.g., bipolar disorder, or major... [+46]